INO vs SHOP · $88.0M cap vs P/E 107, rev $3.58B
Inovio Pharmaceuticals Inc (INO) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
INO currently screens at market cap $88.0M. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the INO and SHOP stock pages for the full models.
Not investment advice.